Curanex Pharmaceuticals Inc
Stock exchange listing-rule deficiency notice (8-K Item 3.01)
The company reported in a Form 8-K (Item 3.01) filed on 06 Nov 2025 that its stock exchange notified it of not meeting a continued-listing rule. Continued non-compliance can lead to delisting.
More details →Quarterly report filed late (NT 10-Q)
The company filed Form NT 10-Q with the SEC on 17 Nov 2025, notifying investors that its quarterly report would be late. Late filings can point to accounting or business problems, though the reason is sometimes routine.
More details →Curanex Pharmaceuticals Inc — Overview & Financial Snapshot
Curanex Pharmaceuticals Inc (NasdaqCM: CURX) is a Healthcare company, ranked #2,014 of 6,774 companies globally and #543 of 4,000 in United States on PositoAI, with a Positivity Score of 22,009. Its market capitalisation is ₹76.97 Cr ($8.15M), P/E ratio is -0.7 and P/B ratio is 1.70. It currently has 1 active red flag (PosiRed) and 1 yellow flag (PosiYellow, 2/10 points) on record.
For financial statements, ratio trends and score history, Go Deep →